>>Lipids>> Lipid-Based Drug Delivery>>306Oi10

306Oi10

Catalog No.GC52090

306Oi10은 전령 RNA의 전달을 위한 지질 나노입자(LNP)를 구성하는 데 사용할 수 있는 분지쇄 이온화 가능한 리피도이드입니다.

Products are for research use only. Not for human use. We do not sell to patients.

306Oi10 Chemical Structure

Cas No.: 2322290-93-5

Size 가격 재고 수량
5mg
US$118.00
재고 있음
10mg
US$189.00
재고 있음
25mg
US$342.00
재고 있음
50mg
US$504.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

306Oi10 is a branched-chain ionizable lipidoid.1 It has been used in the generation of lipid nanoparticles (LNPs). It has strong surface ionization at pH 5, which is the pH in the late endosomal compartment, and a surface pKa value of 6.4 when encapsulating mRNA. LNPs containing 306Oi10 and encapsulating an mRNA reporter accumulate primarily in the mouse liver and those encapsulating erythropoietin increase serum erythropoietin levels in mice. LNPs containing 306Oi10 and encapsulating mRNA encoding the Cas9 nuclease (mCas9) and single-guide RNA targeting LoxP (sgLoxP) have been used to induce CRISPR-mediated gene editing in Ai9 mice that express a floxed STOP codon to prevent tdTomato expression.2

1.Hajj, K.A., Ball, R.L., Deluty, S.B., et al.Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pHSmall15(6)e1805097(2019) 2.Hajj, K.A., Melamed, J.R., Chaudhary, N., et al.A potent branched-tail lipid nanoparticle enables multiplexed mRNA delivery and gene editing in vivoNano Lett.20(7)5167-5175(2020)

리뷰

Review for 306Oi10

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 306Oi10

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.